How to recognise and what to do about pulmonary sarcoidosis

E. Renzoni (London, United Kingdom)

Source: International Congress 2019 – State of the art session: Interstitial lung diseases
Session: State of the art session: Interstitial lung diseases
Session type: Symposium
Number: 3526
Disease area: Interstitial lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Renzoni (London, United Kingdom). How to recognise and what to do about pulmonary sarcoidosis. International Congress 2019 – State of the art session: Interstitial lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The study of pulmonary circulation in the patients with pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001

Pulmonary sarcoidosis
Source: Eur Respir Monogr 2022; 96: 122-141
Year: 2022


Pulmonary hypertension is common in end-stage sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012


VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Renal involvement in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 550s
Year: 2005

Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001

Charectristics of pulmonary cavitary lesion in patients with pulmonary TB
Source: Eur Respir J 2004; 24: Suppl. 48, 284s
Year: 2004

Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Pathogenesis of pulmonary fibrosis in sarcoidosis
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020


CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis
Source: Eur Respir J 2016; 47: 673-676
Year: 2016


Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2003; 22: Suppl. 45, 247s
Year: 2003

Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006

Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2004; 24: Suppl. 48, 199s
Year: 2004

Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD?
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Comprehensive evaluation of airway involvement in pulmonary sarcoidosis
Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016
Year: 2017



Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016
Year: 2017



Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012